PATRICIA KEEGAN: Open Payments
NPI 1285141697 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 60 payments from 23 companies in 2025. Trend: 2023 $1,644 · 2024 $2,429 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $321 |
| Novartis Pharmaceuticals Corporation | 12 | $223 |
| Amgen Inc. | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Merck Sharp & Dohme LLC | 4 | $62 |
| Actelion Pharmaceuticals US, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
Products named: CARDIOMEMS, LEQVIO, REPATHA, JARDIANCE, Kerendia, BRILINTA, Assure WCD, EVKEEZA.
Industry payments across IN — which companies pay providers there.
